| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.498 | 0.051 | 0.59 | Cyclophilin D inhibitor | 0.59 0.029 CID_11694142 | CID_11694142 | |
| 0.41 | 0.025 | 0.41 | Potassium channel (Voltage-sensitive) blocker | 0.238 0.073 CID_11694142 | ||
| 0.39 | 0.005 | 0.39 | Ca(v)3.3 blocker | 0.336 0.019 CID_11694142 | ||
| 0.365 | 0.006 | 0.383 | NADPH oxidase inhibitor | 0.383 0.005 CID_11694142 | CID_11694142 | |
| 0.347 | 0.004 | 0.347 | Nav1.8 sodium channel blocker | 0.31 0.004 CID_11694142 | ||
| 0.374 | 0.032 | 0.374 | HERG channel blocker | 0.23 0.075 CID_11694142 | ||
| 0.346 | 0.005 | 0.346 | Nav1.6 sodium channel blocker | 0.284 0.007 CID_11694142 | ||
| 0.333 | 0.062 | 0.333 | Calcium channel activator | 0.294 0.097 CID_11694142 | ||
| 0.282 | 0.013 | 0.282 | Sodium channel blocker | 0.174 0.043 CID_11694142 | ||
| 0.278 | 0.014 | 0.278 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | 0.27 0.015 CID_11694142 | ||
| 0.266 | 0.003 | 0.266 | Glutamate (mGluR7) agonist | 0.185 0.005 CID_11694142 | ||
| 0.274 | 0.014 | 0.274 | Abl kinase inhibitor | 0.264 0.015 CID_11694142 | ||
| 0.287 | 0.028 | 0.331 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.331 0.016 CID_11694142 | CID_11694142 | |
| 0.255 | 0.004 | 0.255 | Glutamate release inhibitor | 0.221 0.004 CID_11694142 | ||
| 0.267 | 0.022 | 0.267 | Nitric-oxide synthase stimulant | 0.26 0.026 CID_11694142 | ||
| 0.253 | 0.014 | 0.253 | Sodium channel (voltage-gated) blocker | 0.159 0.048 CID_11694142 | ||
| 0.284 | 0.048 | 0.395 | Amyloid beta aggregation inhibitor | 0.395 0.025 CID_11694142 | CID_11694142 | |
| 0.278 | 0.046 | 0.312 | Tyrosine 3 hydroxylase inhibitor | 0.312 0.028 CID_11694142 | CID_11694142 | |
| 0.234 | 0.003 | 0.256 | GABA B receptor agonist | 0.256 0.003 CID_11694142 | CID_11694142 | |
| 0.282 | 0.053 | 0.282 | Potassium channel blocker | |||
| 0.282 | 0.055 | 0.357 | 5 Hydroxytryptamine uptake stimulant | 0.357 0.023 CID_11694142 | CID_11694142 | |
| 0.235 | 0.009 | 0.264 | CF transmembrane conductance regulator agonist | 0.264 0.005 CID_11694142 | CID_11694142 | |
| 0.222 | 0.005 | 0.28 | Myeloperoxidase inhibitor | 0.28 0.004 CID_11694142 | CID_11694142 | |
| 0.275 | 0.061 | 0.304 | Antiamyloidogenic | 0.304 0.05 CID_11694142 | CID_11694142 | |
| 0.275 | 0.066 | 0.317 | Transcription factor STAT3 inhibitor | 0.317 0.045 CID_11694142 | CID_11694142 | |
| 0.243 | 0.035 | 0.243 | Growth factor agonist | 0.239 0.037 CID_11694142 | ||
| 0.265 | 0.065 | 0.345 | Superoxide dismutase inhibitor | 0.345 0.037 CID_11694142 | CID_11694142 | |
| 0.212 | 0.017 | 0.212 | Nav1.1 sodium channel blocker | 0.201 0.019 CID_11694142 | ||
| 0.251 | 0.057 | 0.251 | Anticonvulsant | 0.234 0.063 CID_11694142 | ||
| 0.183 | 0.01 | 0.183 | Electron transport complex I inhibitor | 0.147 0.022 CID_11694142 | ||
| 0.192 | 0.02 | 0.237 | Carbonic anhydrase XV inhibitor | 0.237 0.013 CID_11694142 | CID_11694142 | |
| 0.184 | 0.016 | 0.184 | Nav1.5 sodium channel blocker | 0.139 0.035 CID_11694142 | ||
| 0.201 | 0.034 | 0.201 | Nav1.2 sodium channel blocker | 0.171 0.046 CID_11694142 | ||
| 0.169 | 0.008 | 0.226 | NMDA 2B receptor antagonist | 0.226 0.005 CID_11694142 | CID_11694142 | |
| 0.177 | 0.015 | 0.237 | AMP-activated protein kinase stimulant | 0.237 0.007 CID_11694142 | CID_11694142 | |
| 0.195 | 0.034 | 0.203 | Hemostatic | 0.203 0.031 CID_11694142 | CID_11694142 | |
| 0.271 | 0.112 | 0.33 | Transcription factor NF kappa B inhibitor | 0.33 0.083 CID_11694142 | CID_11694142 | |
| 0.18 | 0.024 | 0.193 | Sphingosine 1-phosphate receptor 5 antagonist | 0.193 0.015 CID_11694142 | CID_11694142 | |
| 0.296 | 0.145 | 0.306 | Analgesic | 0.306 0.137 CID_11694142 | CID_11694142 | |
| 0.181 | 0.032 | 0.181 | Nav1.3 sodium channel blocker | 0.143 0.052 CID_11694142 | ||
| 0.235 | 0.087 | 0.253 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.253 0.062 CID_11694142 | CID_11694142 | |
| 0.161 | 0.016 | 0.179 | Aminoacyl-tRNA synthetase inhibitor | 0.179 0.013 CID_11694142 | CID_11694142 | |
| 0.189 | 0.044 | 0.232 | MAO inhibitor | 0.232 0.032 CID_11694142 | CID_11694142 | |
| 0.186 | 0.045 | 0.246 | Catenin beta inhibitor | 0.246 0.012 CID_11694142 | CID_11694142 | |
| 0.182 | 0.043 | 0.182 | Tubulin antagonist | |||
| 0.163 | 0.024 | 0.21 | Papain-like protease (SARS coronavirus) inhibitor | 0.21 0.009 CID_11694142 | CID_11694142 | |
| 0.16 | 0.024 | 0.191 | Pim-1 kinase inhibitor | 0.191 0.016 CID_11694142 | CID_11694142 | |
| 0.187 | 0.052 | 0.187 | Polo-like kinase-3 inhibitor | 0.179 0.058 CID_11694142 | ||
| 0.3 | 0.165 | 0.3 | 5 Hydroxytryptamine release inhibitor | 0.272 0.198 CID_11694142 | ||
| 0.166 | 0.032 | 0.209 | MAO B inhibitor | 0.209 0.023 CID_11694142 | CID_11694142 | |
| 0.145 | 0.012 | 0.145 | Phosphodiesterase 11A inhibitor | 0.087 0.046 CID_11694142 | ||
| 0.145 | 0.012 | 0.145 | Phosphodiesterase XI inhibitor | 0.087 0.046 CID_11694142 | ||
| 0.233 | 0.1 | 0.302 | Transcription factor STAT inhibitor | 0.302 0.054 CID_11694142 | CID_11694142 | |
| 0.162 | 0.03 | 0.311 | GABA C receptor agonist | 0.311 0.009 CID_11694142 | CID_11694142 | |
| 0.16 | 0.028 | 0.172 | Heat shock protein 70 antagonist | 0.172 0.016 CID_11694142 | CID_11694142 | |
| 0.231 | 0.099 | 0.231 | 5 Hydroxytryptamine release stimulant | 0.231 0.099 CID_11694142 | ||
| 0.16 | 0.033 | 0.16 | Interleukin 1b antagonist | |||
| 0.148 | 0.023 | 0.148 | Alpha 2a adrenoreceptor antagonist | 0.085 0.045 CID_11694142 | ||
| 0.153 | 0.029 | 0.161 | DNA repair enzyme inhibitor | 0.161 0.023 CID_11694142 | CID_11694142 | |
| 0.146 | 0.024 | 0.146 | Nitric-oxide synthase inhibitor | 0.133 0.031 CID_11694142 | ||
| 0.127 | 0.005 | 0.127 | TRPM8 blocker | 0.096 0.007 CID_11694142 | ||
| 0.128 | 0.006 | 0.147 | Glutamate (mGluR group III) agonist | 0.147 0.005 CID_11694142 | CID_11694142 | |
| 0.14 | 0.019 | 0.303 | NMDA 2 receptor antagonist | 0.303 0.005 CID_11694142 | CID_11694142 | |
| 0.125 | 0.004 | 0.125 | MAP kinase 7 inhibitor | 0.11 0.005 CID_11694142 | ||
| 0.128 | 0.008 | 0.128 | 5 Hydroxytryptamine 2A agonist | 0.088 0.021 CID_11694142 | ||
| 0.123 | 0.004 | 0.123 | Calcium channel P-type blocker | 0.075 0.021 CID_11694142 | ||
| 0.123 | 0.005 | 0.123 | Potassium channel intermediate-conductance Ca-activated blocker | 0.087 0.013 CID_11694142 | ||
| 0.121 | 0.004 | 0.121 | Diamine oxidase inhibitor | 0.097 0.004 CID_11694142 | ||
| 0.195 | 0.078 | 0.211 | Insulin sensitizer | 0.211 0.063 CID_11694142 | CID_11694142 | |
| 0.126 | 0.009 | 0.126 | Acetylcholine M5 receptor agonist | 0.088 0.028 CID_11694142 | ||
| 0.181 | 0.065 | 0.387 | Peroxidase inhibitor | 0.387 0.022 CID_11694142 | CID_11694142 | |
| 0.139 | 0.023 | 0.139 | Stem cell growth factor agonist | 0.103 0.042 CID_11694142 | ||
| 0.194 | 0.079 | 0.206 | Histone acetyltransferase inhibitor | 0.206 0.061 CID_11694142 | CID_11694142 | |
| 0.121 | 0.008 | 0.121 | Kallikrein inhibitor | 0.098 0.011 CID_11694142 | ||
| 0.121 | 0.009 | 0.149 | Kallikrein 1 inhibitor | 0.149 0.007 CID_11694142 | CID_11694142 | |
| 0.114 | 0.005 | 0.114 | Plasma kallikrein inhibitor | 0.088 0.005 CID_11694142 | ||
| 0.166 | 0.057 | 0.185 | Thiol protease inhibitor | 0.185 0.046 CID_11694142 | CID_11694142 | |
| 0.169 | 0.06 | 0.189 | Melanin inhibitor | 0.189 0.046 CID_11694142 | CID_11694142 | |
| 0.111 | 0.008 | 0.123 | Factor IXa inhibitor | 0.123 0.005 CID_11694142 | CID_11694142 | |
| 0.111 | 0.008 | 0.157 | Plasminogen activator inhibitor antagonist | 0.157 0.005 CID_11694142 | CID_11694142 | |
| 0.199 | 0.099 | 0.346 | Free radical scavenger | 0.346 0.04 CID_11694142 | CID_11694142 | |
| 0.124 | 0.024 | 0.124 | Rho-associated kinase II inhibitor | 0.068 0.059 CID_11694142 | ||
| 0.117 | 0.018 | 0.117 | Nav1.7 sodium channel blocker | |||
| 0.109 | 0.013 | 0.109 | 5 Hydroxytryptamine 5 antagonist | 0.055 0.045 CID_11694142 | ||
| 0.113 | 0.017 | 0.166 | D-Ala-D-Ala ligase inhibitor | 0.166 0.004 CID_11694142 | CID_11694142 | |
| 0.228 | 0.133 | 0.228 | Caspase 3 stimulant | 0.223 0.139 CID_11694142 | ||
| 0.13 | 0.035 | 0.208 | DOPA decarboxylase inhibitor | 0.208 0.005 CID_11694142 | CID_11694142 | |
| 0.153 | 0.06 | 0.153 | Cytokine production inhibitor | 0.124 0.085 CID_11694142 | ||
| 0.153 | 0.061 | 0.153 | Neuropeptide Y1 antagonist | 0.14 0.081 CID_11694142 | ||
| 0.167 | 0.078 | 0.167 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.093 | 0.004 | 0.093 | 5 Hydroxytryptamine 2B agonist | 0.05 0.013 CID_11694142 | ||
| 0.118 | 0.031 | 0.118 | Polo-like kinase-1 inhibitor | |||
| 0.095 | 0.01 | 0.095 | 5 Hydroxytryptamine 2 agonist | 0.057 0.03 CID_11694142 | ||
| 0.101 | 0.016 | 0.152 | Maillard reaction inhibitor | 0.152 0.005 CID_11694142 | CID_11694142 | |
| 0.136 | 0.053 | 0.225 | Monophenol monooxygenase inhibitor | 0.225 0.028 CID_11694142 | CID_11694142 | |
| 0.097 | 0.015 | 0.097 | Aryl hydrocarbon receptor antagonist | 0.079 0.028 CID_11694142 | ||
| 0.288 | 0.207 | 0.288 | Caspase 9 stimulant | |||
| 0.121 | 0.04 | 0.19 | Potassium channel (Ca-activated) activator | 0.19 0.017 CID_11694142 | CID_11694142 | |
| 0.133 | 0.052 | 0.135 | Sphingosine 1-phosphate receptor 4 antagonist | 0.135 0.05 CID_11694142 | CID_11694142 | |
| 0.252 | 0.175 | 0.385 | Antibacterial | 0.385 0.084 CID_11694142 | CID_11694142 | |
| 0.124 | 0.048 | 0.181 | GABA C receptor antagonist | 0.181 0.017 CID_11694142 | CID_11694142 | |
| 0.107 | 0.031 | 0.107 | Inducible nitric-oxide synthase inhibitor | 0.096 0.04 CID_11694142 | ||
| 0.166 | 0.091 | 0.193 | Platelet adhesion inhibitor | 0.193 0.075 CID_11694142 | CID_11694142 | |
| 0.164 | 0.089 | 0.207 | Succinate dehydrogenase inhibitor | 0.207 0.043 CID_11694142 | CID_11694142 | |
| 0.099 | 0.024 | 0.099 | Ca(v)3.1 blocker | 0.098 0.025 CID_11694142 | ||
| 0.114 | 0.043 | 0.184 | HIV-1 integrase (Overall Integration) inhibitor | 0.184 0.015 CID_11694142 | CID_11694142 | |
| 0.081 | 0.011 | 0.083 | Glucose-6-phosphate translocase inhibitor | 0.083 0.01 CID_11694142 | CID_11694142 | |
| 0.183 | 0.114 | 0.264 | Aldehyde oxidase inhibitor | 0.264 0.077 CID_11694142 | CID_11694142 | |
| 0.078 | 0.012 | 0.078 | 5 Hydroxytryptamine 2C agonist | 0.061 0.02 CID_11694142 | ||
| 0.146 | 0.08 | 0.149 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.149 0.074 CID_11694142 | CID_11694142 | |
| 0.14 | 0.075 | 0.169 | Protein kinase stimulant | 0.169 0.056 CID_11694142 | CID_11694142 | |
| 0.108 | 0.043 | 0.108 | Alpha 2 adrenoreceptor antagonist | |||
| 0.106 | 0.042 | 0.106 | 5 Hydroxytryptamine 2C antagonist | |||
| 0.147 | 0.083 | 0.171 | Anticoagulant | 0.171 0.066 CID_11694142 | CID_11694142 | |
| 0.13 | 0.067 | 0.13 | Vanilloid 1 agonist | 0.13 0.066 CID_11694142 | ||
| 0.107 | 0.044 | 0.107 | Ca(v)2.2 blocker | |||
| 0.075 | 0.012 | 0.075 | Ryanodine receptor antagonist | 0.063 0.029 CID_11694142 | ||
| 0.102 | 0.039 | 0.132 | Bcr-Abl kinase inhibitor | 0.132 0.021 CID_11694142 | CID_11694142 | |
| 0.083 | 0.021 | 0.083 | Protease activated receptor antagonist | |||
| 0.098 | 0.037 | 0.098 | CYP2A6 inhibitor | 0.081 0.048 CID_11694142 | ||
| 0.176 | 0.117 | 0.176 | Aryl hydrocarbon receptor agonist | 0.149 0.136 CID_11694142 | ||
| 0.063 | 0.004 | 0.063 | Cholesterol ester transfer protein antagonist | 0.049 0.007 CID_11694142 | ||
| 0.123 | 0.065 | 0.123 | Beta amyloid protein antagonist | |||
| 0.141 | 0.085 | 0.178 | Phospholipase A2 inhibitor | 0.178 0.055 CID_11694142 | CID_11694142 | |
| 0.143 | 0.087 | 0.201 | Thrombolytic | 0.201 0.052 CID_11694142 | CID_11694142 | |
| 0.076 | 0.021 | 0.076 | Alpha tubulin antagonist | 0.073 0.023 CID_11694142 | ||
| 0.064 | 0.009 | 0.064 | Dihydrofolate reductase inhibitor | 0.043 0.033 CID_11694142 | ||
| 0.067 | 0.012 | 0.067 | Sphingosine 1-phosphate receptor agonist | 0.061 0.016 CID_11694142 | ||
| 0.101 | 0.047 | 0.259 | NMDA receptor antagonist | 0.259 0.009 CID_11694142 | CID_11694142 | |
| 0.13 | 0.076 | 0.145 | Alkaline phosphatase inhibitor | 0.145 0.063 CID_11694142 | CID_11694142 | |
| 0.086 | 0.033 | 0.088 | Sphingosine 1-phosphate receptor 4 agonist | 0.088 0.032 CID_11694142 | CID_11694142 | |
| 0.092 | 0.038 | 0.092 | Thioredoxin reductase inhibitor | 0.091 0.039 CID_11694142 | ||
| 0.104 | 0.051 | 0.104 | Breast cancer-resistant protein inhibitor | |||
| 0.06 | 0.009 | 0.06 | Tryptase inhibitor | 0.059 0.009 CID_11694142 | ||
| 0.056 | 0.005 | 0.056 | Vanilloid 3 antagonist | 0.046 0.012 CID_11694142 | ||
| 0.133 | 0.083 | 0.184 | Cell wall synthesis inhibitor | 0.184 0.038 CID_11694142 | CID_11694142 | |
| 0.174 | 0.124 | 0.174 | 5 Hydroxytryptamine 3E antagonist | 0.174 0.124 CID_11694142 | ||
| 0.067 | 0.018 | 0.086 | Adenine nucleotide translocase inhibitor | 0.086 0.007 CID_11694142 | CID_11694142 | |
| 0.051 | 0.003 | 0.051 | Complement factor D inhibitor | 0.037 0.004 CID_11694142 | ||
| 0.085 | 0.037 | 0.085 | Epoxide hydrolase inhibitor | 0.078 0.044 CID_11694142 | ||
| 0.075 | 0.027 | 0.156 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.156 0.006 CID_11694142 | CID_11694142 | |
| 0.077 | 0.03 | 0.077 | Orexin receptor antagonist | |||
| 0.081 | 0.034 | 0.081 | Orexin receptor 1 antagonist | |||
| 0.09 | 0.043 | 0.11 | Carbonic anhydrase XIII inhibitor | 0.11 0.033 CID_11694142 | CID_11694142 | |
| 0.127 | 0.081 | 0.135 | Sphingosine 1-phosphate receptor 2 antagonist | 0.135 0.064 CID_11694142 | CID_11694142 | |
| 0.092 | 0.047 | 0.092 | Granulocyte macrophage colony stimulating factor agonist | 0.081 0.072 CID_11694142 | ||
| 0.075 | 0.031 | 0.086 | Beta adrenoreceptor antagonist | 0.086 0.023 CID_11694142 | CID_11694142 | |
| 0.148 | 0.104 | 0.148 | Tumour necrosis factor antagonist | |||
| 0.063 | 0.019 | 0.063 | Vanilloid 2 antagonist | 0.062 0.021 CID_11694142 | ||
| 0.075 | 0.034 | 0.075 | Glutamate (mGluR7) antagonist | |||
| 0.069 | 0.028 | 0.069 | Potassium channel (Ca-activated) blocker | |||
| 0.063 | 0.022 | 0.077 | Beta 2 adrenoreceptor antagonist | 0.077 0.013 CID_11694142 | CID_11694142 | |
| 0.089 | 0.048 | 0.111 | Carbonic anhydrase VI inhibitor | 0.111 0.033 CID_11694142 | CID_11694142 | |
| 0.067 | 0.026 | 0.085 | Ca(v)3.2 blocker | 0.085 0.013 CID_11694142 | CID_11694142 | |
| 0.054 | 0.014 | 0.054 | Substance P antagonist | |||
| 0.081 | 0.043 | 0.081 | Metalloproteinase-9 inhibitor | 0.08 0.044 CID_11694142 | ||
| 0.084 | 0.047 | 0.103 | Na+ K+ transporting ATPase inhibitor | 0.103 0.029 CID_11694142 | CID_11694142 | |
| 0.064 | 0.028 | 0.064 | Phosphodiesterase II inhibitor | |||
| 0.195 | 0.158 | 0.217 | Hypoxia-inducible factor 1 alpha inhibitor | 0.217 0.132 CID_11694142 | CID_11694142 | |
| 0.106 | 0.07 | 0.113 | Mucolytic | 0.113 0.061 CID_11694142 | CID_11694142 | |
| 0.076 | 0.041 | 0.082 | Amidase inhibitor | 0.082 0.036 CID_11694142 | CID_11694142 | |
| 0.048 | 0.013 | 0.048 | Peroxisome proliferator-activated receptor delta agonist | 0.034 0.023 CID_11694142 | ||
| 0.099 | 0.065 | 0.123 | MAO A inhibitor | 0.123 0.051 CID_11694142 | CID_11694142 | |
| 0.052 | 0.018 | 0.052 | Sphingosine 1-phosphate receptor 1 agonist | 0.05 0.02 CID_11694142 | ||
| 0.059 | 0.026 | 0.085 | Glycine transporter 2 inhibitor | 0.085 0.016 CID_11694142 | CID_11694142 | |
| 0.069 | 0.036 | 0.076 | Beta 3 adrenoreceptor antagonist | 0.076 0.027 CID_11694142 | CID_11694142 | |
| 0.059 | 0.026 | 0.059 | Peroxisome proliferator-activated receptor alpha agonist | 0.046 0.035 CID_11694142 | ||
| 0.064 | 0.032 | 0.069 | Beta 1 adrenoreceptor antagonist | 0.069 0.027 CID_11694142 | CID_11694142 | |
| 0.073 | 0.041 | 0.073 | Phosphodiesterase 4B inhibitor | |||
| 0.06 | 0.029 | 0.061 | Epithelial sodium channel blocker | 0.061 0.027 CID_11694142 | CID_11694142 | |
| 0.076 | 0.046 | 0.076 | Potassium channel (Tandem pore domain) blocker | |||
| 0.06 | 0.03 | 0.064 | Sphingosine 1-phosphate receptor 1 antagonist | 0.064 0.024 CID_11694142 | CID_11694142 | |
| 0.083 | 0.054 | 0.083 | Transforming growth factor beta 3 antagonist | |||
| 0.066 | 0.036 | 0.066 | Beta tubulin antagonist | 0.05 0.046 CID_11694142 | ||
| 0.056 | 0.027 | 0.056 | Phosphodiesterase 2A inhibitor | |||
| 0.049 | 0.02 | 0.049 | Factor VIIa inhibitor | 0.045 0.022 CID_11694142 | ||
| 0.047 | 0.018 | 0.047 | Glutamate (mGluR group II) antagonist | 0.037 0.029 CID_11694142 | ||
| 0.107 | 0.079 | 0.126 | Proteasome inhibitor | 0.126 0.06 CID_11694142 | CID_11694142 | |
| 0.045 | 0.018 | 0.045 | Protein kinase (CK1) epsilon inhibitor | |||
| 0.064 | 0.038 | 0.064 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.135 | 0.108 | 0.135 | Protein kinase (CK1) gamma 3 inhibitor | 0.135 0.107 CID_11694142 | ||
| 0.144 | 0.118 | 0.151 | Neurotensin receptor agonist | 0.151 0.098 CID_11694142 | CID_11694142 | |
| 0.075 | 0.049 | 0.107 | Histone deacetylase SIRT1 stimulant | 0.107 0.024 CID_11694142 | CID_11694142 | |
| 0.075 | 0.049 | 0.107 | Histone deacetylase stimulant | 0.107 0.024 CID_11694142 | CID_11694142 | |
| 0.101 | 0.076 | 0.188 | Cystathionine beta-synthase inhibitor | 0.188 0.027 CID_11694142 | CID_11694142 | |
| 0.201 | 0.175 | 0.201 | Vasodilator, peripheral | |||
| 0.093 | 0.067 | 0.108 | Lanosterol 14 alpha demethylase inhibitor | 0.108 0.045 CID_11694142 | CID_11694142 | |
| 0.039 | 0.015 | 0.039 | Dipeptidyl peptidase II inhibitor | 0.036 0.018 CID_11694142 | ||
| 0.037 | 0.013 | 0.045 | Glutamate (mGluR3) agonist | 0.045 0.007 CID_11694142 | CID_11694142 | |
| 0.087 | 0.063 | 0.092 | Pim-3 kinase inhibitor | 0.092 0.056 CID_11694142 | CID_11694142 | |
| 0.2 | 0.177 | 0.217 | Antithrombotic | 0.217 0.158 CID_11694142 | CID_11694142 | |
| 0.072 | 0.049 | 0.072 | Peroxisome proliferator-activated receptor gamma antagonist | 0.071 0.05 CID_11694142 | ||
| 0.071 | 0.048 | 0.071 | Peroxisome proliferator-activated receptor gamma agonist | 0.062 0.056 CID_11694142 | ||
| 0.032 | 0.01 | 0.032 | Hedgehog signaling activator | |||
| 0.04 | 0.019 | 0.049 | Phosphoglycerate kinase inhibitor | 0.049 0.014 CID_11694142 | CID_11694142 | |
| 0.062 | 0.042 | 0.08 | Beta 2 adrenoreceptor agonist | 0.08 0.009 CID_11694142 | CID_11694142 | |
| 0.091 | 0.071 | 0.091 | Sphingomyelinase inhibitor | |||
| 0.026 | 0.006 | 0.026 | Dipeptidyl peptidase IX inhibitor | 0.025 0.007 CID_11694142 | ||
| 0.029 | 0.01 | 0.047 | Dopamine D1 agonist | 0.047 0.005 CID_11694142 | CID_11694142 | |
| 0.061 | 0.042 | 0.07 | TRPA1 antagonist | 0.07 0.033 CID_11694142 | CID_11694142 | |
| 0.061 | 0.043 | 0.061 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.045 | 0.026 | 0.053 | Nerve growth factor antagonist | 0.053 0.015 CID_11694142 | CID_11694142 | |
| 0.043 | 0.025 | 0.054 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.054 0.011 CID_11694142 | CID_11694142 | |
| 0.036 | 0.018 | 0.036 | Melatonin receptor 1A agonist | |||
| 0.038 | 0.02 | 0.038 | Tryptophan 5 hydroxylase inhibitor | 0.036 0.025 CID_11694142 | ||
| 0.211 | 0.194 | 0.361 | GABA C receptor rho-3 antagonist | 0.361 0.08 CID_11694142 | CID_11694142 | |
| 0.075 | 0.058 | 0.081 | Sphingosine 1-phosphate receptor antagonist | 0.081 0.044 CID_11694142 | CID_11694142 | |
| 0.133 | 0.117 | 0.142 | Antipruritic | 0.142 0.104 CID_11694142 | CID_11694142 | |
| 0.049 | 0.033 | 0.056 | Dopamine beta hydroxylase inhibitor | 0.056 0.019 CID_11694142 | CID_11694142 | |
| 0.041 | 0.024 | 0.041 | Glucagon-like peptide 1 receptor antagonist | 0.037 0.035 CID_11694142 | ||
| 0.049 | 0.032 | 0.049 | Glycine transporter inhibitor | |||
| 0.021 | 0.005 | 0.021 | Prokineticin receptor 1 antagonist | |||
| 0.062 | 0.047 | 0.062 | Transcription factor RelA inhibitor | |||
| 0.112 | 0.097 | 0.112 | Calcium channel blocker | |||
| 0.054 | 0.04 | 0.071 | Sphingosine kinase 2 inhibitor | 0.071 0.021 CID_11694142 | CID_11694142 | |
| 0.035 | 0.021 | 0.035 | Peroxisome proliferator-activated receptor delta antagonist | |||
| 0.024 | 0.01 | 0.024 | Imidazoline I1 receptor antagonist | |||
| 0.028 | 0.015 | 0.028 | Epoxide hydrolase 2 inhibitor | 0.026 0.016 CID_11694142 | ||
| 0.103 | 0.09 | 0.103 | Calcium channel N-type blocker | |||
| 0.058 | 0.046 | 0.058 | Adrenaline uptake inhibitor | |||
| 0.031 | 0.019 | 0.031 | Glutamate (mGluR2) antagonist | |||
| 0.028 | 0.016 | 0.028 | Calcium-sensing receptor agonist | |||
| 0.067 | 0.056 | 0.067 | Polo-like kinase-2 inhibitor | |||
| 0.091 | 0.08 | 0.094 | Expectorant | 0.094 0.076 CID_11694142 | CID_11694142 | |
| 0.076 | 0.066 | 0.076 | Phosphodiesterase IV inhibitor | |||
| 0.066 | 0.056 | 0.066 | Secretase beta inhibitor | |||
| 0.06 | 0.05 | 0.065 | Neutrophil collagenase inhibitor | 0.065 0.044 CID_11694142 | CID_11694142 | |
| 0.043 | 0.034 | 0.043 | Potassium channel small-conductance Ca-activated blocker | |||
| 0.035 | 0.026 | 0.035 | Orexin receptor 2 antagonist | |||
| 0.057 | 0.048 | 0.126 | Purinergic P2X1 antagonist | 0.126 0.01 CID_11694142 | CID_11694142 | |
| 0.078 | 0.07 | 0.078 | Histamine H2 receptor antagonist | |||
| 0.062 | 0.053 | 0.062 | 5 Hydroxytryptamine agonist | |||
| 0.065 | 0.057 | 0.065 | Exportin-1 inhibitor | |||
| 0.015 | 0.007 | 0.017 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.017 0.005 CID_11694142 | CID_11694142 | |
| 0.136 | 0.129 | 0.15 | ATPase inhibitor | 0.15 0.101 CID_11694142 | CID_11694142 | |
| 0.045 | 0.038 | 0.058 | Cholesterol esterase inhibitor | 0.058 0.019 CID_11694142 | CID_11694142 | |
| 0.016 | 0.009 | 0.016 | Dipeptidyl peptidase VIII inhibitor | 0.015 0.011 CID_11694142 | ||
| 0.053 | 0.047 | 0.053 | 5 Hydroxytryptamine 7 agonist | |||
| 0.046 | 0.04 | 0.054 | Bombesin 2 receptor antagonist | 0.054 0.029 CID_11694142 | CID_11694142 | |
| 0.029 | 0.024 | 0.029 | Potassium channel small-conductance Ca-activated activator | |||
| 0.052 | 0.046 | 0.079 | Dihydroorotate oxidase inhibitor | 0.079 0.011 CID_11694142 | CID_11694142 | |
| 0.012 | 0.007 | 0.012 | Imidazoline I2 receptor antagonist | |||
| 0.11 | 0.105 | 0.11 | Interleukin 1 antagonist | |||
| 0.078 | 0.074 | 0.095 | Estrogen-related receptor beta agonist | 0.095 0.031 CID_11694142 | CID_11694142 | |
| 0.056 | 0.052 | 0.08 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.08 0.019 CID_11694142 | CID_11694142 | |
| 0.049 | 0.045 | 0.109 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.109 0.009 CID_11694142 | CID_11694142 | |
| 0.018 | 0.014 | 0.018 | Factor IX inhibitor | |||
| 0.029 | 0.025 | 0.029 | Epoxide hydrolase 1 inhibitor | |||
| 0.047 | 0.044 | 0.047 | Factor III inhibitor | 0.047 0.045 CID_11694142 | ||
| 0.095 | 0.092 | 0.095 | Calcium channel (voltage-sensitive) blocker | |||
| 0.03 | 0.028 | 0.034 | Liver X receptor beta agonist | 0.034 0.022 CID_11694142 | CID_11694142 | |
| 0.103 | 0.101 | 0.103 | Acetylcholinesterase inhibitor | |||
| 0.035 | 0.033 | 0.035 | Alpha 1d adrenoreceptor agonist | |||
| 0.015 | 0.013 | 0.023 | Purinergic P2Y1 antagonist | 0.023 0.007 CID_11694142 | CID_11694142 | |
| 0.037 | 0.035 | 0.041 | Phenylethanolamine N methyltransferase inhibitor | 0.041 0.027 CID_11694142 | CID_11694142 | |
| 0.033 | 0.031 | 0.037 | Antibiotic Aminoglycoside-like | 0.037 0.024 CID_11694142 | CID_11694142 | |
| 0.038 | 0.037 | 0.038 | Plasmepsin II inhibitor | |||
| 0.053 | 0.052 | 0.053 | Collagenase 3 inhibitor | |||
| 0.015 | 0.014 | 0.015 | G-protein-coupled receptor 120 agonist | |||
| 0.068 | 0.068 | 0.075 | Metalloproteinase-2 inhibitor | 0.075 0.058 CID_11694142 | CID_11694142 | |
| 0.067 | 0.067 | 0.072 | Glutamate receptor agonist | 0.072 0.06 CID_11694142 | CID_11694142 | |
| 0.046 | 0.046 | 0.086 | CD45 antagonist | 0.086 0.011 CID_11694142 | CID_11694142 | |
| 0.026 | 0.028 | 0.03 | Purinergic P2Y14 antagonist | 0.03 0.02 CID_11694142 | CID_11694142 | |
| 0.16 | 0.162 | 0.203 | Hypoglycemic | 0.203 0.109 CID_11694142 | CID_11694142 | |
| 0.023 | 0.026 | 0.029 | Sodium/glucose cotransporter inhibitor | 0.029 0.012 CID_11694142 | CID_11694142 | |
| 0.014 | 0.018 | 0.017 | Cyclin T1 inhibitor | 0.017 0.015 CID_11694142 | CID_11694142 | |
| 0.072 | 0.077 | 0.089 | Glutathione S-transferase inhibitor | 0.089 0.049 CID_11694142 | CID_11694142 | |
| 0.089 | 0.095 | 0.112 | Nav1.4 sodium channel blocker | 0.112 0.06 CID_11694142 | CID_11694142 | |
| 0.047 | 0.052 | 0.052 | Pim-2 kinase inhibitor | 0.052 0.042 CID_11694142 | CID_11694142 | |
| 0.026 | 0.032 | 0.044 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.044 0.014 CID_11694142 | CID_11694142 | |
| 0.055 | 0.063 | 0.059 | Trypsin inhibitor | 0.059 0.051 CID_11694142 | CID_11694142 | |
| 0.057 | 0.065 | 0.068 | Carbonic anhydrase VA inhibitor | 0.068 0.049 CID_11694142 | CID_11694142 | |
| 0.06 | 0.068 | 0.248 | Porphobilinogen synthase inhibitor | 0.248 0.008 CID_11694142 | CID_11694142 | |
| 0.018 | 0.027 | 0.025 | Protein 30S ribosomal subunit inhibitor | 0.025 0.016 CID_11694142 | CID_11694142 | |
| 0.009 | 0.018 | 0.013 | Calcium-dependent phospholipase A2 inhibitor | 0.013 0.007 CID_11694142 | CID_11694142 | |
| 0.08 | 0.09 | 0.088 | Potassium channel (Voltage-sensitive) activator | 0.088 0.071 CID_11694142 | CID_11694142 | |
| 0.019 | 0.029 | 0.022 | Isoleucine-tRNA ligase inhibitor | 0.022 0.018 CID_11694142 | CID_11694142 | |
| 0.036 | 0.049 | 0.045 | Dihydroorotase inhibitor | 0.045 0.03 CID_11694142 | CID_11694142 | |
| 0.042 | 0.057 | 0.072 | Plasminogen activator inhibitor | 0.072 0.03 CID_11694142 | CID_11694142 | |
| 0.03 | 0.046 | 0.072 | Dopamine D5 agonist | 0.072 0.008 CID_11694142 | CID_11694142 | |
| 0.017 | 0.033 | 0.029 | Prostaglandin F2 alpha agonist | 0.029 0.009 CID_11694142 | CID_11694142 | |
| 0.029 | 0.045 | 0.069 | Estradiol 17 beta-dehydrogenase inhibitor | 0.069 0.016 CID_11694142 | CID_11694142 | |
| 0.027 | 0.044 | 0.033 | Glutamate (mGluR4) agonist | 0.033 0.026 CID_11694142 | CID_11694142 | |
| 0.031 | 0.049 | 0.04 | Glutamate (mGluR8) agonist | 0.04 0.023 CID_11694142 | CID_11694142 | |
| 0.095 | 0.114 | 0.116 | Toll-Like receptor 2 antagonist | 0.116 0.082 CID_11694142 | CID_11694142 | |
| 0.027 | 0.046 | 0.044 | Protein kinase (CK2) beta inhibitor | 0.044 0.009 CID_11694142 | CID_11694142 | |
| 0.035 | 0.053 | 0.049 | CF transmembrane conductance regulator antagonist | 0.049 0.009 CID_11694142 | CID_11694142 | |
| 0.05 | 0.069 | 0.062 | Carbonic anhydrase V inhibitor | 0.062 0.051 CID_11694142 | CID_11694142 | |
| 0.012 | 0.031 | 0.016 | Antibiotic Tetracycline-like | 0.016 0.01 CID_11694142 | CID_11694142 | |
| 0.03 | 0.05 | 0.043 | Urokinase inhibitor | 0.043 0.037 CID_11694142 | CID_11694142 | |
| 0.056 | 0.077 | 0.108 | Glutamate decarboxylase inhibitor | 0.108 0.026 CID_11694142 | CID_11694142 | |
| 0.042 | 0.063 | 0.059 | Alpha-mannosidase inhibitor | 0.059 0.028 CID_11694142 | CID_11694142 | |
| 0.04 | 0.062 | 0.047 | Aconitate hydratase inhibitor | 0.047 0.043 CID_11694142 | CID_11694142 | |
| 0.032 | 0.054 | 0.04 | Plasmin inhibitor | 0.04 0.039 CID_11694142 | CID_11694142 | |
| 0.062 | 0.084 | 0.082 | Keratolytic | 0.082 0.045 CID_11694142 | CID_11694142 | |
| 0.125 | 0.148 | 0.141 | Ca2+-transporting ATPase inhibitor | 0.141 0.071 CID_11694142 | CID_11694142 | |
| 0.068 | 0.091 | 0.089 | MAP kinase kinase 7 inhibitor | 0.089 0.026 CID_11694142 | CID_11694142 | |
| 0.072 | 0.096 | 0.101 | NADH dehydrogenase inhibitor | 0.101 0.042 CID_11694142 | CID_11694142 | |
| 0.114 | 0.139 | 0.16 | Adenylate cyclase stimulant | 0.16 0.047 CID_11694142 | CID_11694142 | |
| 0.017 | 0.043 | 0.035 | Glucagon receptor antagonist | 0.035 0.017 CID_11694142 | CID_11694142 | |
| 0.011 | 0.038 | 0.032 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.032 0.011 CID_11694142 | CID_11694142 | |
| 0.191 | 0.219 | 0.244 | Antiobesity | 0.244 0.162 CID_11694142 | CID_11694142 | |
| 0.036 | 0.064 | 0.05 | Protein kinase C epsilon inhibitor | 0.05 0.041 CID_11694142 | CID_11694142 | |
| 0.014 | 0.045 | 0.022 | Beta 1 adrenoreceptor agonist | 0.022 0.016 CID_11694142 | CID_11694142 | |
| 0.031 | 0.062 | 0.05 | Mannosidase inhibitor | 0.05 0.025 CID_11694142 | CID_11694142 | |
| 0.049 | 0.082 | 0.125 | Histidine decarboxylase inhibitor | 0.125 0.024 CID_11694142 | CID_11694142 | |
| 0.075 | 0.107 | 0.119 | Ferrochelatase inhibitor | 0.119 0.054 CID_11694142 | CID_11694142 | |
| 0.045 | 0.078 | 0.071 | Sphingosine kinase inhibitor | 0.071 0.024 CID_11694142 | CID_11694142 | |
| 0.06 | 0.093 | 0.116 | Adrenaline agonist | 0.116 0.027 CID_11694142 | CID_11694142 | |
| 0.038 | 0.072 | 0.05 | Beta adrenoreceptor agonist | 0.05 0.017 CID_11694142 | CID_11694142 | |
| 0.036 | 0.071 | 0.078 | Alcohol oxidase inhibitor | 0.078 0.025 CID_11694142 | CID_11694142 | |
| 0.14 | 0.176 | 0.209 | Interleukin agonist | 0.209 0.113 CID_11694142 | CID_11694142 | |
| 0.107 | 0.145 | 0.166 | Arachidonic acid antagonist | 0.166 0.07 CID_11694142 | CID_11694142 | |
| 0.072 | 0.112 | 0.096 | Protein kinase C zeta inhibitor | 0.096 0.056 CID_11694142 | CID_11694142 | |
| 0.069 | 0.108 | 0.09 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.09 0.065 CID_11694142 | CID_11694142 | |
| 0.066 | 0.109 | 0.084 | Prolactin inhibitor | 0.084 0.076 CID_11694142 | CID_11694142 | |
| 0.029 | 0.072 | 0.045 | Sphingosine kinase 1 inhibitor | 0.045 0.023 CID_11694142 | CID_11694142 | |
| 0.073 | 0.117 | 0.088 | GABA C receptor rho-1 antagonist | 0.088 0.081 CID_11694142 | CID_11694142 | |
| 0.069 | 0.119 | 0.102 | Carbonic anhydrase III inhibitor | 0.102 0.06 CID_11694142 | CID_11694142 | |
| 0.173 | 0.224 | 0.221 | Apoptosis antagonist | 0.221 0.155 CID_11694142 | CID_11694142 | |
| 0.019 | 0.074 | 0.031 | Estrogen-related receptor gamma antagonist | 0.031 0.014 CID_11694142 | CID_11694142 | |
| 0.047 | 0.102 | 0.086 | Potassium channel large-conductance Ca-activated activator | 0.086 0.031 CID_11694142 | CID_11694142 | |
| 0.052 | 0.107 | 0.07 | GABA aminotransferase inhibitor | 0.07 0.062 CID_11694142 | CID_11694142 | |
| 0.076 | 0.132 | 0.105 | Adenylate kinase inhibitor | 0.105 0.059 CID_11694142 | CID_11694142 | |
| 0.045 | 0.103 | 0.065 | Protein kinase C alpha inhibitor | 0.065 0.052 CID_11694142 | CID_11694142 | |
| 0.034 | 0.093 | 0.064 | Carbamoyl phosphate synthetase inhibitor | 0.064 0.039 CID_11694142 | CID_11694142 | |
| 0.069 | 0.129 | 0.087 | Xanthine oxidase inhibitor | 0.087 0.077 CID_11694142 | CID_11694142 | |
| 0.011 | 0.072 | 0.032 | CXC chemokine 2 receptor antagonist | 0.032 0.012 CID_11694142 | CID_11694142 | |
| 0.069 | 0.13 | 0.148 | Adenylate cyclase inhibitor | 0.148 0.047 CID_11694142 | CID_11694142 | |
| 0.012 | 0.085 | 0.047 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.047 0.017 CID_11694142 | CID_11694142 | |
| 0.023 | 0.097 | 0.045 | NMDA receptor subunit 3B antagonist | 0.045 0.03 CID_11694142 | CID_11694142 | |
| 0.095 | 0.171 | 0.185 | Dual specificity phosphatase 3 inhibitor | 0.185 0.069 CID_11694142 | CID_11694142 | |
| 0.059 | 0.137 | 0.09 | Triose-phosphate isomerase inhibitor | 0.09 0.06 CID_11694142 | CID_11694142 | |
| 0.068 | 0.147 | 0.1 | Protein kinase C gamma inhibitor | 0.1 0.076 CID_11694142 | CID_11694142 | |
| 0.117 | 0.197 | 0.188 | Neurotrophic factor enhancer | 0.188 0.089 CID_11694142 | CID_11694142 | |
| 0.036 | 0.116 | 0.104 | Phenylalanine 4-hydroxylase inhibitor | 0.104 0.024 CID_11694142 | CID_11694142 | |
| 0.058 | 0.139 | 0.143 | Creatine kinase inhibitor | 0.143 0.027 CID_11694142 | CID_11694142 | |
| 0.073 | 0.155 | 0.14 | Alpha-N-acetylglucosaminidase inhibitor | 0.14 0.061 CID_11694142 | CID_11694142 | |
| 0.055 | 0.138 | 0.089 | Potassium channel activator | 0.089 0.062 CID_11694142 | CID_11694142 | |
| 0.018 | 0.103 | 0.064 | NMDA 2A receptor antagonist | 0.064 0.027 CID_11694142 | CID_11694142 | |
| 0.045 | 0.131 | 0.083 | Ornithine decarboxylase inhibitor | 0.083 0.063 CID_11694142 | CID_11694142 | |
| 0.121 | 0.208 | 0.255 | Antioxidant | 0.255 0.081 CID_11694142 | CID_11694142 | |
| 0.037 | 0.128 | 0.074 | Protein kinase C beta inhibitor | 0.074 0.04 CID_11694142 | CID_11694142 | |
| 0.015 | 0.106 | 0.033 | NMDA receptor subunit 3A antagonist | 0.033 0.031 CID_11694142 | CID_11694142 | |
| 0.096 | 0.188 | 0.13 | Nitric oxide antagonist | 0.13 0.118 CID_11694142 | CID_11694142 | |
| 0.11 | 0.202 | 0.194 | Immunostimulant | 0.194 0.124 CID_11694142 | CID_11694142 | |
| 0.053 | 0.146 | 0.092 | Protein kinase C delta inhibitor | 0.092 0.06 CID_11694142 | CID_11694142 | |
| 0.113 | 0.207 | 0.168 | Phospholipase C inhibitor | 0.168 0.075 CID_11694142 | CID_11694142 | |
| 0.101 | 0.194 | 0.126 | Interferon gamma antagonist | 0.126 0.119 CID_11694142 | CID_11694142 | |
| 0.087 | 0.188 | 0.114 | Mannose-6-phosphate isomerase inhibitor | 0.114 0.111 CID_11694142 | CID_11694142 | |
| 0.087 | 0.192 | 0.14 | Hexokinase inhibitor | 0.14 0.091 CID_11694142 | CID_11694142 | |
| 0.027 | 0.133 | 0.086 | Phosphofructokinase-1 inhibitor | 0.086 0.038 CID_11694142 | CID_11694142 | |
| 0.134 | 0.241 | 0.198 | DNA synthesis inhibitor | 0.198 0.126 CID_11694142 | CID_11694142 | |
| 0.057 | 0.164 | 0.096 | Anabolic | 0.096 0.069 CID_11694142 | CID_11694142 | |
| 0.042 | 0.156 | 0.076 | Histamine N-methyltransferase inhibitor | 0.076 0.072 CID_11694142 | CID_11694142 | |
| 0.041 | 0.155 | 0.067 | Glutamate dehydrogenase inhibitor | 0.067 0.061 CID_11694142 | CID_11694142 | |
| 0.035 | 0.15 | 0.054 | Heat shock protein 90 beta antagonist | 0.054 0.051 CID_11694142 | CID_11694142 | |
| 0.05 | 0.17 | 0.079 | Estrogen receptor alpha antagonist | 0.079 0.05 CID_11694142 | CID_11694142 | |
| 0.051 | 0.174 | 0.119 | UDP-glucose 4-epimerase inhibitor | 0.119 0.044 CID_11694142 | CID_11694142 | |
| 0.071 | 0.204 | 0.164 | Angiogenesis stimulant | 0.164 0.114 CID_11694142 | CID_11694142 | |
| 0.045 | 0.18 | 0.078 | Antineoplastic alkaloid | 0.078 0.067 CID_11694142 | CID_11694142 | |
| 0.053 | 0.189 | 0.1 | Glutamate receptor antagonist | 0.1 0.097 CID_11694142 | CID_11694142 | |
| 0.122 | 0.259 | 0.199 | 12-Lipoxygenase inhibitor | 0.199 0.153 CID_11694142 | CID_11694142 | |
| 0.112 | 0.261 | 0.177 | Lipoxygenase inhibitor | 0.177 0.167 CID_11694142 | CID_11694142 | |
| 0.082 | 0.232 | 0.157 | Dual specificity phosphatase inhibitor | 0.157 0.087 CID_11694142 | CID_11694142 | |
| 0.123 | 0.274 | 0.201 | Cholesterol antagonist | 0.201 0.163 CID_11694142 | CID_11694142 | |
| 0.129 | 0.281 | 0.194 | Immunomodulator | 0.194 0.172 CID_11694142 | CID_11694142 | |
| 0.123 | 0.281 | 0.171 | RNA-directed DNA polymerase inhibitor | 0.171 0.15 CID_11694142 | CID_11694142 | |
| 0.017 | 0.182 | 0.032 | Protein kinase C beta I inhibitor | 0.032 0.027 CID_11694142 | CID_11694142 | |
| 0.043 | 0.221 | 0.144 | Chelator | 0.144 0.038 CID_11694142 | CID_11694142 | |
| 0.045 | 0.282 | 0.129 | Protein-tyrosine phosphatase inhibitor | 0.129 0.102 CID_11694142 | CID_11694142 | |
| 0.041 | 0.351 | 0.126 | Estrogen antagonist | 0.126 0.045 CID_11694142 | CID_11694142 | |
| 0.023 | 0.426 | 0.11 | Estrogen receptor beta antagonist | 0.11 0.046 CID_11694142 | CID_11694142 | |
| 0.07 | 0.664 | 0.218 | Interleukin 2 agonist | 0.218 0.16 CID_11694142 | CID_11694142 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |